A selective drug delivery system based on phospholipid-type nanobubbles for lung cancer therapy

Ming Hsien Chan, Yung Chieh Chan, Ru Shi Liu, Michael Hsiao*

*此作品的通信作者

研究成果: Article同行評審

11 引文 斯高帕斯(Scopus)

摘要

To develop a micelle-type nanobubble decorated with fluorescein-5-isothiocyanate-conjugated transferrin, with encapsulation of paclitaxel (PTX@FT-NB) for lung cancer treatment. Materials & methods: PTX@FT-NBs were characterized to determine their physicochemical properties, structural stability and cytotoxicity. Lung cancer cell and mouse xenograft tumor models were used to evaluate the therapeutic effectiveness of PTX@FT-NB. Results: The PTX@FT-NBs not only showed selective targeting to lung cancer cells but also inhibited tumor growth significantly via paclitaxel release. Furthermore, paclitaxel-induced microtubule stabilization demonstrated the release of the drug from PTX@FT-NB in the targeted tumor cell both in vitro and in vivo. Conclusion: PTX@FT-NB has the potential as an anticancer nanocarrier against lung cancer cells because of its specific targeting and better drug delivery capacity.

原文English
頁(從 - 到)2689-2705
頁數17
期刊Nanomedicine
15
發行號27
DOIs
出版狀態Published - 11月 2020

指紋

深入研究「A selective drug delivery system based on phospholipid-type nanobubbles for lung cancer therapy」主題。共同形成了獨特的指紋。

引用此